The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia

被引:0
|
作者
Rachael L. DiSantostefano
Andrea K. Biddle
John P. Lavelle
机构
[1] School of Public Health,Department of Health Policy and Administration
[2] University of North Carolina at Chapel Hill,Carolina Program in Healthcare and Aging Research
[3] Institute on Aging,Division of Urology
[4] University of North Carolina,undefined
[5] School of Medicine,undefined
[6] University of North Carolina,undefined
来源
PharmacoEconomics | 2006年 / 24卷
关键词
Benign Prostatic Hyperplasia; Lower Urinary Tract Symptom; Urinary Symptom; Watchful Waiting; Utility Weight;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:171 / 191
页数:20
相关论文
共 50 条
  • [21] Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
    Tzortzis, Vassilios
    Gravas, Stavros
    de la Rosette, Jean J. M. C. H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (06) : 513 - 522
  • [22] Long-term (4 year) efficacy and tolerability of doxazosin for the treatment of concurrent benign prostatic hyperplasia and hypertension
    Fawzy, A
    Hendry, A
    Cook, E
    Gonzalez, F
    INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (07) : 346 - 354
  • [23] Finasteride: A long-term follow-up in the treatment of recurrent hematuria associated with benign prostatic hyperplasia
    Delakas, D
    Lianos, E
    Karyotis, I
    Cranidis, A
    UROLOGIA INTERNATIONALIS, 2001, 67 (01) : 69 - 72
  • [24] Long-Term Efficacy of Serenoa repens Treatment in Patients with Mild and Moderate Symptomatic Benign Prostatic Hyperplasia
    Sinescu, Ioanel
    Geavlete, Petrisor
    Multescu, Razvan
    Gangu, Constantin
    Miclea, Florin
    Coman, Ioan
    Ioiart, Ioan
    Ambert, Valentin
    Constantin, Traian
    Petrut, Bogdan
    Feciche, Bogdan
    UROLOGIA INTERNATIONALIS, 2011, 86 (03) : 284 - 289
  • [25] HISTOLOGICAL-EVALUATION OF BENIGN PROSTATIC HYPERPLASIA TREATED BY LONG-TERM ADMINISTRATION OF CHLORMADINONE ACETATE (CMA)
    HARADA, M
    KINOSHITA, Y
    MORIYAMA, M
    KONDO, I
    NAKAHASHI, M
    KUMAGAI, H
    SASAKI, K
    HOSAKA, M
    PROSTATE, 1994, 25 (03) : 147 - 155
  • [26] Long-Term Efficacy and Recurrence Prediction of Prostatic Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
    Xu, Zhong-Wei
    Zhou, Chun-Gao
    Tian, Wei
    Shi, Hai-Bin
    Liu, Sheng
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2022, 45 (12) : 1801 - 1809
  • [27] Long-Term Efficacy and Recurrence Prediction of Prostatic Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
    Zhong-Wei Xu
    Chun-Gao Zhou
    Wei Tian
    Hai-Bin Shi
    Sheng Liu
    CardioVascular and Interventional Radiology, 2022, 45 : 1801 - 1809
  • [28] Cost-effectiveness analysis of minimally invasive surgical treatments for benign prostatic hyperplasia: implications for Japan's public healthcare system
    Anezaki, Hisataka
    Endo, Fumiyasu
    Swan, Georgia
    Takashima, Kenta
    Rojanasarot, Sirikan
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 554 - 565
  • [29] Phytotherapy for benign prostatic hyperplasia
    Gerber G.S.
    Current Urology Reports, 2002, 3 (4) : 285 - 291
  • [30] Cost Comparison of Benign Prostatic Hyperplasia Treatment Options
    DeWitt-Foy, Molly E.
    Gill, Bradley C.
    Ulchaker, James C.
    CURRENT UROLOGY REPORTS, 2019, 20 (08)